Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma

BACKGROUND: Minimal residual disease (MRD) is an important prognostic factor for evaluating a deeper treatment response in patients with multiple myeloma (MM). We evaluated the clinical utility of next-generation flow (NGF)-based MRD assessment in a heterogeneous MM patient population. METHODS: Pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyun-Young, Yoo, In Young, Lim, Dae Jin, Kim, Hee-Jin, Kim, Sun-Hee, Yoon, Sang Eun, Kim, Seok Jin, Cho, Duck, Kim, Kihyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Laboratory Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057816/
https://www.ncbi.nlm.nih.gov/pubmed/35470273
http://dx.doi.org/10.3343/alm.2022.42.5.558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057816/
https://www.ncbi.nlm.nih.gov/pubmed/35470273
http://dx.doi.org/10.3343/alm.2022.42.5.558

Ejemplares similares